Temozolomide | NSC 362856 | CCRG 81045 | TMZ

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
500 mg	In-stock	￥688.00	Visible after login	- +
1 g	In-stock	￥1068.00	Visible after login	- +
5 g	In-stock	￥2688.00	Visible after login	- +

Product Overview

Product Name	Temozolomide \| NSC 362856 \| CCRG 81045 \| TMZ
CAS	85622-93-1
Formula	C6H6N6O2
MW	194.15
MDL	MFCD00866492
Appearance	Off-white crystalline powder
Storage condition	-20°C, protect from light, stored under nitroge

Security information

Product details

1. TMZ(Temozolomide) is a monofunctional SN-1 alkylating agent that can modify nitrogen atoms in the DNA ring and the extracyclic oxygen group, chemically converted to MTIC and degrades to methyldiazonium cation, which transfers methyl groups to DNA at physiologic pH. A DNA damage inducer in L-1210 and L-1210/BCNU cells. Temozolomide induces apoptosis and exhibits antitumor activity.

2.Temozolomide (NSC 362856) is an oral active DNA alkylating agent that crosses the blood-brain barrier. Temozolomide is also a proautophagic and proapoptotic agent. Temozolomide is effective against tumor cells that are characterized by low levels of O6-alkylguanine DNA alkyltransferase (OGAT) and a functional mismatch repair system. Temozolomide has antitumor and antiangiogenic effects.

Related literature

Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site.

PMID: 11877304 DOI: 10.1182/blood.v99.6.2241

PMID: 26447477 PMCID: PMC4598115 DOI: 10.1371/journal.pone.0140131

Neoplasia. 2008 Dec;10(12):1383-92.

PMID: 17968428 PMCID: PMC2360470 DOI: 10.1038/sj.bjc.6604017

PMID: 30405885 PMCID: PMC6201851 DOI: 10.18632/oncotarget.26183

History

CL2164

Temozolomide | NSC 362856 | CCRG 81045 | TMZ

85622-93-1 98+%